Response, Survival, and Prognostic Factors After Hepatic Arterial Chemoembolization in Patients With Liver Metastases From Cutaneous Melanoma

被引：15
|
作者：
Ahrar, Judy
Gupta, Sanjay [1 ]
Ensor, Joe [2 ]
Ahrar, Kamran
Madoff, David C.
Wallace, Michael J.
Murthy, Ravi
Tam, Alda
Hwu, Patrick [3 ]
Bedikian, Agop Y. [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Unit 325, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CANCER INVESTIGATION | 2011年 / 29卷 / 01期
关键词：
OCULAR MELANOMA; MALIGNANT-MELANOMA; UVEAL MELANOMA; DISTANT METASTASES; POLYVINYL SPONGE; UNITED-STATES; CHEMOTHERAPY; EMBOLIZATION; CISPLATIN; FOTEMUSTINE;
D O I：
10.3109/07357907.2010.535052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We reviewed the medical records of 42 patients with cutaneous melanoma metastatic to the liver who underwent hepatic artery chemoembolization (HACE) at our institution. HACE resulted in radiologic response (38.9%) or disease stabilization (47.2%) in most patients. The median overall survival (OS) and time to progression (TTP) of liver disease were 7.7 and 6 months, respectively. Patient's age, lactate dehydrogenase (LDH) levels, type of treatment, number of extrahepatic metastatic sites, and response to therapy were found to be significant predictors of OS after HACE. Prolonged survival was seen in patients who responded to HACE (p = .034).</.
引用
收藏
页码：49 / 55
页数：7
相关论文
共 50 条
  • [1] Hepatic Artery Chemoembolization in Patients With Ocular Melanoma Metastatic to the Liver Response, Survival, and Prognostic Factors
    Gupta, Sanjay
    Bedikian, Agop Y.
    Ahrar, Judy
    Ensor, Joe
    Ahrar, Kamran
    Madoff, David C.
    Wallace, Michael J.
    Murthy, Ravi
    Tam, Alda
    Hwu, Patrick
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05): : 474 - 480
  • [2] Survival Outcomes and Prognostic Factors of Transcatheter Arterial Chemoembolization for Hepatic Neuroendocrine Metastases
    Hur, Saebeom
    Chung, Jin Wook
    Kim, Hyo-Cheol
    Oh, Do-Youn
    Lee, Se-Hoon
    Bang, Yung-Jue
    Kim, Woo Ho
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 24 (07) : 947 - 956
  • [3] Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma
    Siegel, R.
    Hauschild, A.
    Kettelhack, C.
    Kaehler, K. C.
    Bembenek, A.
    Schlag, P. M.
    [J]. EJSO, 2007, 33 (05): : 627 - 632
  • [4] Prognostic factors for survival after embolization of hepatic metastases in uveal melanoma
    Yamamoto, A.
    Chervoneva, I.
    Sullivan, K.
    Eschelman, D.
    Gonsalves, C.
    Mastrangelo, M. J.
    Berd, D.
    Feeney, K.
    Terai, M.
    Sato, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Hepatic transarterial chemoembolization (HACE) with cisplatin in liver metastases from cutaneous melanoma: a prospective study of three patients
    Devaux, S.
    Du Thanh, A.
    Gallix, B.
    Girard, C.
    Dereure, O.
    Guillot, B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (02) : E261 - E262
  • [6] Hepatic Metastasis From Uveal Melanoma Angiographic Pattern Predictive of Survival After Hepatic Arterial Chemoembolization
    Dayani, Pouya N.
    Gould, Jennifer E.
    Brown, Daniel B.
    Sharma, Karun V.
    Linette, Gerald P.
    Harbour, J. William
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (05) : 628 - 632
  • [7] Survival and prognostic factors in patients with brain metastases from malignant melanoma
    Meier, S
    Baumert, BG
    Maier, T
    Wellis, G
    Burg, G
    Seifert, B
    Dummer, R
    [J]. ONKOLOGIE, 2004, 27 (02): : 145 - 149
  • [8] REGRESSION OF HEPATIC METASTASES FROM GASTROINTESTINAL LEIOMYOSARCOMA AFTER HEPATIC ARTERIAL CHEMOEMBOLIZATION
    MAVLIGIT, GM
    ZUKIWSKI, AA
    SALEM, PA
    LAMKI, L
    WALLACE, S
    [J]. CANCER, 1991, 68 (02) : 321 - 323
  • [9] Prognostic Factors for Survival in Melanoma Patients With Brain Metastases
    Davies, Michael A.
    Liu, Ping
    McIntyre, Susan
    Kim, Kevin B.
    Papadopoulos, Nicholas
    Hwu, Wen-Jen
    Hwu, Patrick
    Bedikian, Agop
    [J]. CANCER, 2011, 117 (08) : 1687 - 1696
  • [10] Prognostic factors for patients undergoing trans-arterial chemoembolization (TACE) for the treatment of liver metastases from neuroendocrine tumors
    Dong, XD
    Yin, X
    Zeh, HJ
    Bartlett, DL
    Brown, CK
    Carr, BI
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 65 - 65
12345